Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

FOR IMMEDIATE RELEASE ON March 24, 2006

Parkinson Disease Treatments Show Risk for Developing Gambling Problems

EMBARGOED FOR RELEASE UNTIL 1:30 P.M. PT, THURSDAY, APRIL 6, 2006

San Diego -

Some treatments for Parkinson disease may present an increased risk of developing pathological gambling in patients, according to a study presented according to a study that will be presented at the American Academy of Neurology 58th Annual Meeting in San Diego, Calif., April 1 – 8, 2006. Pathological gambling is an impulse control disorder that can cause devastating effects on the personal and professional lives of those who have it. The study surveyed 188 patients with Parkinson disease who were being treated with medication, surgery, or both for their symptoms. Researchers found that six percent of patients with Parkinson disease developed problems with gambling compared to 1.5 percent in the general population. Both dopamine agonist therapies (drugs that activate the dopamine receptor in the brain) and deep brain stimulus (DBS) surgery were associated with gambling. No patients who were prescribed the drugs levodopa, or were non-gamblers before treatment, developed symptoms of pathological gambling. Of those who were on one of more medications, including pramipexole, pergolide, or ropinirole, 10 developed gambling problems. Two of those who had DBS surgery to remedy their Parkinson symptoms developed gambling problems after their operations. “Patients with Parkinson disease who have been gamblers should inform their neurologist about any history of gambling while discussing treatment options,” said study author Oksana Suchowersky, MD, a neuroscience researcher at the University of Calgary in Alberta, Canada. “Consulting with their doctor is the best way to minimize the risk of turning a pastime into a serious concern.” Parkinson disease is due to a loss of nerve cells in an area deep within the brain, called the substantia nigra. This area produces the chemical dopamine. Dopamine helps send signals within the brain. Without the right amount of dopamine, movement can become impaired. Dopamine is also associated with creating pleasurable emotions and positive reinforcement to motivate the brain to do certain activities. DBS surgery involves running an electrical current (similar to a pacemaker for the heart) to an area of the brain near the substantia nigra in order to alleviate tremors caused by Parkinson disease.

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life®, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.

DISCOVER MORE


Subscribe to our email newsletter

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 44,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, LinkedIn, Instagram and YouTube.

Editor's Notes: Dr. Suchowersky will present this research during a scientific platform session at 1:30 p.m. on Thursday, April 6 in room 6CD of the San Diego Convention Center. She will be available for media questions during a briefing at 8:00 a.m., Wednesday, April 5 in the on-site Press Interview Room, room 16 B. All listed times are for Pacific Time (PT). AAN Press Room in the San Diego Convention Center April 1 - April 7, 2006 contact (619) 525-6207

For More Information*

Email media@aan.com

*While content of the American Academy of Neurology (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver website, Brain & Life®.